E. V. D. Steen-Banasik

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

H. Putter, W. V. Putten, R. Nout, 2010, The Lancet.

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991.

L Collette, O Matzinger, M Bolla, 2009, European journal of cancer.

Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups.

J. Jager, V. Budach, J. Bosset, 2003, European journal of cancer.

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

A. Slot, J. Jobsen, V. Smit, 2010, The Lancet.

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).

L. Collette, K. Haustermans, J. Bosset, 2009, European journal of cancer.

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.

E. M. van der Steen-Banasik, H. Westerveld, M. Nowee, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.